Drug Trial Radar · NCT04263363
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Last checked: Nov 19, 2026Latest source record: Jul 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12,248
Actual
Start
Feb 18, 2022
Primary completion
May 7, 2024
Study completion May 7, 2025
Sponsor
- Lead sponsor
- University of California, Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Feb 10, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to: 1. Perform a retrospective analysis on data contained in the UCLA Perioperative Data Warehouse on the incidence of respiratory dysfunction in the post-operative care unit (PACU) before and after the introduction of sugammadex into clinical practice. 2. Develop and implement a clinical best practice pathway designed to prevent postoperative respiratory complications in higher risk patients (such as those with OSA or preexisting respiratory disease) using education and clinical decision support in patients.
Conditions
- Respiratory Complication
- Obstructive Sleep Apnea
Interventions
Sugammadex 100 MG/ML [Bridion]Drug
Sugammadex administered to patients within the clinical best practice pathway.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to "Fitness for Discharge" From the Recovery RoomTime frame: One year prior to study intervention to one year following implementation of study intervention
- Incidence of Hypoxemia in the PACU (Oxygen Saturation Below 90%)Time frame: One year prior to study intervention to one year following implementation of study intervention
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ronald Reagan UCLA Medical Center
Los Angeles, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.